Current Status and Open Issues Concerning Global Clinical Trials (GCTs) in Japan and East Asia
Authors:
Open Access
- 4 July 2017
- journal article
- Published by Wiley in Clinical and Translational Science
- Vol. 10 (6) , 503-508
Abstract
When global clinical trials are carried out, it is important to consider the influence of racial and ethnic differences on the outcome. From this viewpoint, global clinical trials in East Asia, where racial differences are estimated to be small, are now attracting close attention. Under such circumstances, we conducted a survey using the data registered with ClinicalTrial.gov to investigate the status of participation of East Asian countries in global clinical trials and differences in the regions selected for drug development between Japanese enterprises and non-Japanese enterprises. This survey revealed that about 90% of all global clinical trials and those involving East Asian countries were sponsored by non-Japanese enterprises. Global clinical trials involving only East Asia have been accepted as one of the development strategies by Japanese enterprises, but this strategy has not spread widely among non-Japanese enterprises.Keywords
This publication has 8 references indexed in Scilit:
- Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and CaucasiansBritish Journal of Clinical Pharmacology, 2016
- Closing the drug lag for new drug submission and review in Japan: An industry perspectiveClinical Pharmacology & Therapeutics, 2015
- Regulatory Challenges in the Review of Data from Global Clinical Trials: The PMDA PerspectiveClinical Pharmacology & Therapeutics, 2013
- Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA PerspectiveClinical Pharmacology & Therapeutics, 2013
- Multiregional Clinical Trials: Japanese Perspective on Drug Development Strategy and Sample Size for Japanese SubjectsJournal of Biopharmaceutical Statistics, 2012
- Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug DevelopmentDrug Metabolism and Pharmacokinetics, 2012
- Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and AfricansThe Journal of Clinical Pharmacology, 2010
- Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian PopulationsClinical Pharmacology & Therapeutics, 2008